Drug · DIN 02246162
REACTINE COMPLETE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 12, 2026; first marketed March 7, 2003.
- Drug Identification Number (DIN)
- 02246162
- Company (DIN owner)
- Kenvue Canada Inc.Guelph, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Pseudoephedrine, combinations R01BA52
- Class
- Human
- Record last updated
- March 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CETIRIZINE HYDROCHLORIDE | 5 MG | |
| PSEUDOEPHEDRINE HYDROCHLORIDE | 120 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 22, 2013: NOC 14841Supplement to a New Drug Submission (SNDS) · Product name change
- January 23, 2007: NOC 8541New Drug Submission (NDS) · Manufacturer name change
- September 30, 2002: NOC 394New Drug Submission (NDS)